TrialJAMA neurology2017

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.